Bayer Aktienges ADR (OP: BAYRY )
14.03 +0.04 (+0.25%) Streaming Delayed Price Updated: 10:33 AM EDT, Jun 7, 2023 Add to My Watchlist
Headline News about Bayer Aktienges ADR
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
April 27, 2023
Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present...
Bayer Seeks To Double US Revenues Over Next Decade, With Planned R&D Spending Of Around $1B
March 10, 2023
Bayer AG (OTC: BAYRY) intends to shell out around $1 billion on drug research and development in the U.S. in 2023 as it works to double its sales in the U.S. over the next ten years.
EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue
February 15, 2023
Cannabis companies of all sizes are struggling to increase their profit margins and to make that happen, they're implementing different strategies. Lowering prices and premiumizing products are among...
Ionis Regains Rights To Thrombosis Candidate From Bayer
November 04, 2022
Roundup Weedkiller Maker Bayer Won Five Consecutive Cases, Shifting Momentum In Bayer's Favor
October 05, 2022
Bayer AG (OTC: BAYRY) won five jury verdicts in a row in trials that contended its Roundup weed killer caused non-Hodgkin lymphoma. The company battles the remaining cases targeting its Roundup...
After Investor Flak, German Healthcare Giant Bayer Starts Hunt For New CEO: Report
September 14, 2022
Deere Invests Billions In Self-Driving Tractors, Smart Crop Sprayers: Report
September 12, 2022
Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug
September 08, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following